(Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced the publication of results from a prior Phase 2 clinical study evaluating ...
Credit: Getty Images. The goal of HCT is to cure an underlying malignancy or hematologic disorder. The procedure can be performed in an inpatient or outpatient setting. Each setting is associated with ...
The Anthony Nolan Cell Collection Centre has welcomed the first people to donate their stem cells for lifesaving transplants and medical research. Creating 1,300 new donation slots a year, the centre ...
Stem cells form the backbone of many cell-based therapies due to their unique properties, including the ability to self-renew and differentiate to many cell types. Multiple cell therapies deliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results